Skip to main content

Table 5 Efficiency of cefaclor in patients with in vitro resistance to specific antibiotics including levofloxacin and cefazolin

From: Cefaclor as a first-line treatment for acute uncomplicated cystitis: a retrospective single-center study

Antimicrobial agentnSuccessPathogennSuccess
Levofloxacin24 (10.3)24 (100)Escherichia coli17 (70.8)17 (100)
Escherichia coli-ESBL1 (4.1)1 (100)
Cefazolin15 (6.4)14 (93.3)Escherichia coli3 (20.0)3 (100)
Escherichia coli-ESBL3 (20.0)2 (66.6)
Levofloxacin and cefazolin15 (6.4)9 (60.0)Escherichia coli1 (6.7)1 (100)
Escherichia coli-ESBL14 (93.3)8 (57.1)
  1. Unless otherwise stated, number of patients with percentages in parentheses
  2. ESBL Extended spectrum beta-lactamase